The European Antibody Congress is the most comprehensive event of its kind. From discovery, development and applications to regulation, alliances, partnering and scale-up. This is your chance to share information with the world’s foremost experts.

7 reasons why YOU should attend: A strategic event – participate in a carefully researched programme designed to cover the issues relevant to you. 38 senior speakers already confirmed – listen to the right people and get a wide range of unique and up-to-the-minute information that will help you stay ahead of the competition and maintain or extend your market share.  Interactivity – the European Antibody Congress is a forum for the exchange of strategies and ideas. We offer four informal discussion sessions where you can ask the questions you want answered! You will not get a better chance than this to question the leading players in the antibody industry, all under one roof. Consider it an unfair advantage! Networking – we are committed to providing you with a range of opportunities for effective networking and an environment in which all attendees can meet, do business and explore shared concerns. In addition to extended coffee breaks, buffet lunches and an evening networking reception we have introduced the exciting and popular Speed Networking. Separately bookable manufacturing day – with the demand for high volumes of antibody products increasing all the time, issues relating to manufacturing and scale-up have never been more relevant. Join our dedicated day on 3rd November to hear the views of 11 experts in this field. Contact - you don’t have to wait until the event to start your discussions though. The sooner you book the sooner you will be able to join our revolutionary Contact system, enabling you to email fellow attendees and arrange meetings before you arrive. It also provides the facility to download conference presentations when you return home. Workshop – the event kicks off with a one-day interactive workshop hosted by PharmaVentures Ltd. Join an interactive and informal day to discuss and develop strategies that will help you optimise alliances within the industry. Places are strictly limited so book today.

European Antibody Congress Speakers include:

Prof Jan van de Winkel, Chief Scientific Officer, Genmab A/S	Mr John Dingerdissen, Vice President, Johnson & Johnson	Dr Lincoln Tsang, Partner, Arnold and Porter, Chairman, Bioindustry Association	Dr Robert S Adamson, Vice President, Wyeth Biopharma Development Network	Dr Bernard Chan, Head of Biologicals Manufacturing Development, UCB Celltech
Dr Clive Wood, CSO, Dyax	Dr Lutz Jermutus, Director of Protein Engineering, Cambridge Antibody Technology	Dr Trudi Veldman, Director, Biologics Generation Abbott Bioresearch Centre	Dr Philip Frost, Chief Scientific Officer, ImClone	Prof Mats Ohlin, Department of Immunotechnology, Lund University, Sweden